Projects per year
Fingerprint
Dive into the research topics where Linda Baughn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry
Baughn, L. (PI)
9/19/23 → 8/31/25
Project: Research project
-
Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry
Baughn, L. (PI)
9/22/22 → 8/31/23
Project: Research project
-
Correction to: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis (Leukemia, (2022), 36, 4, (1058-1065), 10.1038/s41375-021-01454-4)
Visram, A., Vachon, C., Baughn, L. B., Larson, D., Smadbeck, J., Dispenzieri, A., Kapoor, P., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Hayman, S. R., Dingli, D., Kourelis, T., Gonsalves, W., Warsame, R., Muchtar, E., Leung, N., Kyle, R. A., Rajkumar, S. V. & Kumar, S., Aug 2024, In: Leukemia. 38, 8, p. 1865 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients
Gagnon, M. F., Bruehl, F. K., Sill, D. R., Meyer, R. G., Greipp, P. T., Hoppman, N. L., Xu, X., Baughn, L. B., Peterson, J. F., McPhail, E. D., Ketterling, R. P. & King, R. L., Jun 2024, In: Journal of Hematopathology. 17, 2, p. 51-61 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis
Lee, Y., Baughn, L. B., Myers, C. L. & Sachs, Z., Dec 2024, In: Blood cancer journal. 14, 1, 80.Research output: Contribution to journal › Letter › peer-review
Open Access -
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms
Jevremovic, D., Shi, M., Horna, P., Otteson, G. E., Timm, M. M., Baughn, L. B., Greipp, P. T., Gonsalves, W. I., Kapoor, P., Gertz, M. A., Binder, M., Buadi, F. K., Zhou, J., Dispenzieri, A., Kourelis, T., Muchtar, E., Rajkumar, S. V., Kumar, S. K. & Olteanu, H., Dec 2024, In: Blood cancer journal. 14, 1, 126.Research output: Contribution to journal › Letter › peer-review
Open Access -
Section E6.1–6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes
ACMG Laboratory Quality Assurance Committee, Apr 2024, In: Genetics in Medicine. 26, 4, 101054.Research output: Contribution to journal › Article › peer-review
Open Access